- Home
- GNFT vs EVM Comparison
GNFT vs EVM Comparison
Compare GNFT & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- EVM
- Stock Information
- Founded
- GNFT 1999
- EVM 2002
- Country
- GNFT France
- EVM United States
- Employees
- GNFT N/A
- EVM N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- EVM Finance/Investors Services
- Sector
- GNFT Health Care
- EVM Finance
- Exchange
- GNFT Nasdaq
- EVM Nasdaq
- Market Cap
- GNFT 216.7M
- EVM 235.5M
- IPO Year
- GNFT 2019
- EVM N/A
- Fundamental
- Price
- GNFT $3.97
- EVM $9.55
- Analyst Decision
- GNFT Strong Buy
- EVM
- Analyst Count
- GNFT 2
- EVM 0
- Target Price
- GNFT $10.00
- EVM N/A
- AVG Volume (30 Days)
- GNFT 8.5K
- EVM 55.8K
- Earning Date
- GNFT 09-22-2025
- EVM 01-01-0001
- Dividend Yield
- GNFT N/A
- EVM 4.01%
- EPS Growth
- GNFT N/A
- EVM N/A
- EPS
- GNFT N/A
- EVM 0.20
- Revenue
- GNFT $52,994,715.00
- EVM N/A
- Revenue This Year
- GNFT $3.14
- EVM N/A
- Revenue Next Year
- GNFT N/A
- EVM N/A
- P/E Ratio
- GNFT N/A
- EVM $47.61
- Revenue Growth
- GNFT N/A
- EVM N/A
- 52 Week Low
- GNFT $2.55
- EVM $7.67
- 52 Week High
- GNFT $6.42
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- GNFT 51.40
- EVM 67.29
- Support Level
- GNFT $3.91
- EVM $9.53
- Resistance Level
- GNFT $4.10
- EVM $9.74
- Average True Range (ATR)
- GNFT 0.16
- EVM 0.07
- MACD
- GNFT 0.02
- EVM -0.01
- Stochastic Oscillator
- GNFT 61.40
- EVM 37.59
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.